Journal
ONCOTARGET
Volume 6, Issue 26, Pages 22361-22374Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4293
Keywords
NANOG; NANOGP8; gene knockout; CRISPR/Cas9; prostate cancer
Categories
Funding
- MEXT KAKENHI [26670156]
- Grants-in-Aid for Scientific Research [26670156] Funding Source: KAKEN
Ask authors/readers for more resources
NANOG expression in prostate cancer is highly correlated with cancer stem cell characteristics and resistance to androgen deprivation. However, it is not clear whether NANOG or its pseudogenes contribute to the malignant potential of cancer. We established NANOG- and NANOGP8-knockout DU145 prostate cancer cell lines using the CRISPR/Cas9 system. Knockouts of NANOG and NANOGP8 significantly attenuated malignant potential, including sphere formation, anchorage-independent growth, migration capability, and drug resistance, compared to parental DU145 cells. NANOG and NANOGP8 knockout did not inhibit in vitro cell proliferation, but in vivo tumorigenic potential decreased significantly. These phenotypes were recovered in NANOG-and NANOGP8-rescued cell lines. These results indicate that NANOG and NANOGP8 proteins are expressed in prostate cancer cell lines, and NANOG and NANOGP8 equally contribute to the high malignant potential of prostate cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available